Titlebook: Anticoagulants, Antiplatelets, and Thrombolytics; Shaker A. Mousa Book 2010Latest edition Springer Science+Business Media, LLC 2010 Anti-X

vein220

書目名稱Anticoagulants, Antiplatelets, and Thrombolytics影響因子(影響力)




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics影響因子(影響力)學科排名




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics網(wǎng)絡公開度




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics網(wǎng)絡公開度學科排名




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics被引頻次




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics被引頻次學科排名




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics年度引用




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics年度引用學科排名




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics讀者反饋




書目名稱Anticoagulants, Antiplatelets, and Thrombolytics讀者反饋學科排名

HAUNT

Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban,treatment of pulmonary embolism, secondary prevention after acute coronary syndromes, and the prevention of stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation. The need for new oral anticoagulants, the development and pharmacology of rivaroxaban, results

令人悲傷

Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist,t response, and faster onset of activity compared to clopidogrel. Recent findings from large-scale phase-III testing show prasugrel to be more efficacious in preventing ischemic events in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI); however, this is achieved

gangrene

Adhesion Molecules: Potential Therapeutic and Diagnostic Implications,d on the key role of CAMs, with special emphasis on integrins in various diseases, as well as the structure–function aspects of cell adhesion and signaling of the different CAMs and ECM are highlighted.

Provenance

Diagnosis and Management of Sickle Cell Disorders,xperience. This chapter brings together a detailed etiology, pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular weight heparin (

ARY

1064-3745 getting optimal results.Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the978-1-4939-6097-2978-1-60761-803-4Series ISSN 1064-3745 Series E-ISSN 1940-6029

Stress-Fracture

怕失去錢

https://doi.org/10.1007/978-3-322-88746-7treatment of pulmonary embolism, secondary prevention after acute coronary syndromes, and the prevention of stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation. The need for new oral anticoagulants, the development and pharmacology of rivaroxaban, results

詳細目錄

https://doi.org/10.1007/978-3-658-28020-8t response, and faster onset of activity compared to clopidogrel. Recent findings from large-scale phase-III testing show prasugrel to be more efficacious in preventing ischemic events in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI); however, this is achieved

Adenoma

,Vorstudie für Studien 2 und 3,d on the key role of CAMs, with special emphasis on integrins in various diseases, as well as the structure–function aspects of cell adhesion and signaling of the different CAMs and ECM are highlighted.